• Cover; Title Page; Copyright Page; Brief Contents; Contents; Preface; Acknowledgments; About the Author;
• Chapter 1 The Microbial World: An Introduction; Good Morning Microbes!; 1.1 Microbiology and Society: A Connected World; 1.2 Why Microbes Matter: Protecting the Planet; The Ocean Microbiome; The Soil Microbiome; The Microbiome of the Atmosphere; The Microbiome in Earth's Crust; 1.3 Why Microbes Matter: Helping Maintain Human Health; 1.4 Why Microbes Matter: Causing Infections and Disease; 1.5 Why Microbes Matter: Benefiting Society; With Most Meals; In the Environment

• A CLOSER LOOK 1.1: Microbes to the Rescue!In the Pharmaceutical/Biotechnology Industries; 1.6 Microbiology Today: Challenges Remain; Air Travel; Urbanization and Poverty; Drug-Resistant Pathogens; Climate Change; A Final Thought; Chapter Discussion Questions;
• Chapter 2 Microbes in Perspective: The Pioneers, Classifiers, and Observers; What Shall We Call This One?; 2.1 The Roots of Microbiology: The Pioneers; Robert Hooke (1635-1703); Antony van Leeuwenhoek (1632-1723); Louis Pasteur (1822-1895); A CLOSER LOOK 2.1: Experimentation and Scientific Inquiry; Robert Koch (1843-1910)

• The Golden Age of Microbiology (1857-1917)2.2 Naming Microbes: What's in a Name?; Binomial Nomenclature; 2.3 The Microbial World: The Observers; Microbial Measurements and Cell Size; A CLOSER LOOK 2.2: "What's in a Name?"; The Light Microscope; The Electron Microscope; 2.4 Microbial Groups: Eukaryotes, Prokaryotes, and Viruses; Eukaryotic Microorganisms; Prokaryotic Organisms; The Viruses; 2.5 Taxonomy: Cataloging Life; Cataloging and Organizing Life; The Tree of Life; The Tree of Life and Society; A Final Thought; Chapter Discussion Questions

• Chapter 3 Molecules of the Cell: The Building Blocks of LifeThe Spark; 3.1 Chemistry Basics: Atoms, Bonds, and Molecules; Atoms and Bonding; Water; A CLOSER LOOK 3.1: Water and Life; The Molecules of Microbes; 3.2 Carbohydrates: Simple Sugars and Polysaccharides; Simple Sugars; Oligosaccharides and Polysaccharides; A CLOSER LOOK 3.2: How Sweet It Is; 3.3 Lipids: Fats, Phospholipids, and Sterols; Fats and Oils; Phospholipids; Sterols; 3.4 Proteins: Amino Acids and Polypeptides; Amino Acids; Polypeptides and Protein Shape; 3.5 Nucleic Acids: DNA and RNA; A Final Thought

• Chapter Discussion Questions
• Chapter 4 Exploring the Prokaryotic World: The Bacteria and Archaea Domains; Hail Caesar!; A CLOSER LOOK 4.1: Bacteria in Eight Easy Lessons1; 4.1 Cell Structure: Shapes and Arrangements; Prokaryotic Cell Shape and Arrangement; Staining Techniques; 4.2 Cell Structure: Anatomy of a Cell; Surface Structures; Surface Projections; A CLOSER LOOK 4.2: Diarrhea Doozies; Cytoplasmic Structures; 4.3 Prokaryotic Reproduction and Survival: Binary Fission and Endospores; Prokaryotic Reproduction; Measuring Prokaryotic Growth; Endospores

• The singer's body : alignment, movement, and intention
• Respiratory kinematics
• Laryngeal anatomy, physiology, and function during singing
• Neurologic control of voice production
• Resonance and vocal acoustics
• Perceptions, aesthetics and registration in the commercial vocal athlete
• Impact of phonotrauma on vocal health and singing
• Common vocal pathologies in vocal athletes : a medical perspective
• Multidisciplinary care of the vocal athlete
• Laryngeal reflux : what the singer needs to know / Adam D. Rubin and Cristina Jackson-Menaldi
• The singer's guide to anesthesiology and voice / Samuel A. Schechtman and Andrew Rosenberg
• Life cycle of the voice
• Medicine, myths and truths
• History of classical voice pedagogy
• Belting : pedagogical considerations
• Physiology of belting : research and theory
• Exercise physiology principals for training the vocal athlete
• Application of motor learning principals to voice training
• The art of perfection : what every singer should know about audio technology / Matthew Edwards.

• 1. Bioremediation : a sustainable approach for management of environmental contaminants / Pardeep Singh, Vipin Kumar Singh, Rishikesh Singh, Anwesha Borthakur, Sughosh Madhav, Arif Ahamad, Ajay Kumar, Dan Bahadur Pal, Dhanesh Tiwary, P.K. Mishra
• 2. Pollution status and biodegradation of organophosphate pesticides in the environment / Mohd Ashraf Dar, Garima Kaushik and Juan Francisco Villareal Chiu
• 3. Recent trends in the detection and degradation of organic pollutants / Preetismita Borah, Manish Kumar and Pooja Devi
• 4. Phytoremediation of organic pollutants: current status and future directions / Sachchidanand Tripathi, Vipin Kumar Singh, Pratap Srivastava, Rishikesh Singh, Rajkumari Sanayaima Devi, Arun Kumar, Rahul Bhadouria
• 5. Bioremediation of dyes from textile and dye manufacturing industry effluent / Razia Khan, Vipul Patel and Zeenat Khan
• 6. Mycoremediation of polycyclic aromatic hydrocarbons / Shalini Gupta and Bhawana Pathak
• 7. Plant growth–promoting rhizobacteria and their functional role in salinity stress management / Akanksha Gupta, Sandeep Kumar Singh, Manoj Kumar Singh, Vipin Kumar Singh, Arpan Modi, Prashant Kumar Singh, Ajay Kumar
• 8. Plant growth–promoting bacteria and their role in environmental management / Divya Singh, Sandeep Kumar Singh, Vipin Kumar Singh, Akanksha Gupta, Mohd Aamir, Ajay Kumar
• 9. Fungi as potential candidates for bioremediation / Rajesh Kumar Singh, Ruchita Tripathi, Amit Ranjan, Akhileshwar Kumar Srivastava
• 10. Cyanobacteria : potential and role for environmental remediation / Priyanka, Cash Kumar, Antra Chatterjee, Wang Wenjing, Deepanker Yadav, Prashant Kumar Singh

• 11. An effective approach for the degradation of phenolic waste : phenols and cresols / Tripti Singh, A.K. Bhatiya, P.K. Mishra, Neha Srivastava
• 12. Environmental fate of organic pollutants and effect on human health / Manita Thakur and Deepak Pathania
• 13. Rhizospheric remediation of organic pollutants from the soil; a green and sustainable technology for soil clean up / Akanksha Gupta, Amit Kumar Patel, Deepak Gupta, Gurudatta Singh, Virendra Kumar Mishra
• 14. The role of scanning probe microscopy in bacteria investigations and bioremediation / Igor V. Yaminsky and Assel I. Akhmetova
• 15. Research progress of biodegradable materials in reducing environmental pollution / Kangming Tian and Muhammad Bilal
• 16. Genetically engineered bacteria for the degradation of dye and other organic compounds / Arvind Kumar, Ajay Kumar, Rishikesh Singh, Raghwendra Singh, Shilpi Pandey, Archana Rai, Vipin Kumar Singh, Bhadouria Rahul.

Abatement of Environmental Pollutants: Trends and Strategies addresses new technologies and provides strategies for environmental scientists, microbiologists and biotechnologists to help solve problems associated with the treatment of industrial wastewater. The book helps readers solve pollution challenges using microorganisms in bioremediation technologies, including discussions on global technologies that have been adopted for the treatment of industrial wastewater and sections on the lack of proper management. Moreover, limited space, more stringent waste disposal regulations and public consciousness have made the present techniques expensive and impractical. Therefore, there is an urgent need to develop sustainable management technologies for industries and municipalities. To remove the damaging effect of organic pollutants on the environment, various new technologies for their degradation have been recently discovered.
(source: Nielsen Book Data)

• Part I: Science and clincial oncology. Section A: Biology and cancer. Molecular tools in cancer research
• Intracellular signaling
• The cellular microenvironment and metastases
• Control of the cell cycle
• The pathophysiology of cancer cell death
• Cancer immunology
• Stem cells, cell differentiation, and cancer
• Vascular and interstitial biology of tumors
• Cancer metabolism
• Section B: Genesis of cancer. Environmental factors
• DNA damage response pathways and cancer
• Viruses and human cancer
• Genetic factors: hereditary cancer predisposition syndromes
• Genetic and epigenetic changes in cancer
• Section C: Diagnosis of cancer. Pathology, biomarkers, and molecular diagnostics
• Imaging
• Section D: Clinical trials. Biostatistics and bioinformatics in clinical trials
• Trial design
• Structures supporting cancer clinical trials
• Oncology and health care policy
• Section E: Prevention and early detection. Discovery and characterization of cancer genetic susceptibility alleles
• Lifestyle and cancer prevention
• Cancer screening and early detection
• Nicotine dependence: current treatments and future directions
• Section F: Treatment. Cancer pharmacology
• Therapeutic targeting of cancer cells: era of molecularly targeted agents
• Basics of radiation therapy
• Hematopoietic stem cell transplantation
• Gene therapy in oncology
• Therapeutic antibodies and immunologic conjugates
• Complementary and alternative medicine
• Part II: Problems common to cancer and therapy
• Section A: Hematologic problems and infections. Disorders of blood cell production in clinical oncology
• Diagnosis, treatment, and prevention of cancer-related venous thrombosis
• Infection in the patient with cancer
• Section B: Symptom management. Hypercalcemia
• Tumor lysis syndrome
• Cancer-related pain
• Cancer cachexia
• Nausea and vomiting
• Section C: Treatment complications. Oral complications
• Dermatologic toxicities of anticancer therapy
• Cardiovascular effects of cancer therapy
• Reproductive complications
• Paraneoplastic neurologic syndromes
• Neurologic complications
• Endocrine complications
• Pulmonary complications of anticancer treatment
• Section D: post treatment considerations. Rehabilitation of individuals with cancer
• Survivorship
• Second malignant neoplasms
• Caring for patients at the end of life
• Section E: Local effects of cancer and its metastasis. Acute abdomen, bowel obstruction, and fistula
• Superior vena cava syndrome
• Spinal cord compression
• Brain metastases and neoplastic meningitis
• Bone metastases
• Lung metastases
• Liver metastases
• Malignancy-related effusions
• Section F: Special populations. Cancer in the elderly: biology, prevention, and treatment
• Special issues in pregnancy
• Human immunodeficiency virus (HIV) infection and cancer --

• Part III: Specific malignancies. Section A: Central nervous system. Cancer of the central nervous system
• Section B: Head, neck, and eye. Ocular tumors
• Cancer of the head and neck
• Section C: Skin. Melanoma
• Nonmelanoma skin cancers: basal cell and squamous cell carcinomas
• Section D: Endocrine. Cancer of the endocrine system
• Section E: Thoracic. Cancer of the lung: non-small cell lung cancer and small cell lung cancer
• Diseases of the pleura and mediastinum
• Cancer of the esophagus and gastroesophageal junction
• Section F: Gastrointestinal. Cancer of the stomach and gastroesophageal junction
• Cancer of the small bowel
• Colon cancer
• Cancer of the rectum
• Cancer of the anal canal
• Liver and bile duct cancer
• Carcinoma of the pancreas
• Section G: Genitourinary. Cancer of the kidney
• Carcinoma of the bladder
• Prostate cancer
• Cancer of the penis
• Testicular cancer
• Section H: Gynecological. Cancers of the cervix, vulva, and vagina
• Cancer of the endometrium
• Ovaries and fallopian tubes
• Gestational trophoblastic disease
• Cancer of the breast
• Section I: Sarcomas. Sarcomas of bone
• Sarcomas of soft tissue
• Section J: Cancer of undefined site of origin. Carcinoma of Unknown Primary
• Section K: Pediatrics. Pediatric solid tumors
• Childhood leukemia
• Childhood lymphoma
• Section L: Hematological. Acute leukemias in adults
• Myelodysplastic syndromes
• Myeloproliferative disorders
• Chronic myeloid leukemia
• Chronic lymphoid leukemias
• Hairy cell leukemia
• Multiple myeloma and related disorders
• Hodgkin's Lymphoma
• Non-Hodgkin lymphoma
• Cutaneous T-cell lymphoma and cutaneous B-cell lymphoma
• Adult T-cell leukemia-lymphoma.

"Easily accessible and clinically focused, Abeloff's Clinical Oncology, 6th Edition, covers recent advances in our understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression, new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading cancer experts, it offers clear, practical coverage of everything from basic science to multidisciplinary collaboration on diagnosis, staging, treatment and follow up"--Publisher's description.

• Abeloff's Clinical Oncology Sixth Edition
• PART I: SCIENCE AND CLINCIAL ONCOLOGY SECTION A: BIOLOGY AND CANCER
• 1. Molecular Tools in Cancer Research
• 2. Intracellular Signaling
• 3. The Cellular Microenvironment and Metastases
• 4. Control of the Cell Cycle
• 5. The Pathophysiology of Cancer Cell Death
• 6. Cancer Immunology
• 7. Stem Cells, Cell Differentiation, and Cancer
• 8. Vascular and Interstitial Biology of Tumors
• 9. Cancer Metabolism SECTION B: GENESIS OF CANCER
• 10. Environmental Factors
• 11. DNA Damage Response Pathways and Cancer
• 12. Viruses and Human Cancer
• 13. Genetic Factors: Hereditary Cancer Predisposition Syndromes
• 14. Genetic and Epigenetic Changes in Cancer SECTION C: DIAGNOSIS OF CANCER
• 15. Pathology, Biomarkers, and Molecular Diagnostics
• 16. Imaging SECTION D: CLINICAL TRIALS
• 17. Biostatistics and Bioinformatics in Clinical Trials
• 18. Trial Design
• 19. Structures Supporting Cancer Clinical Trials
• 20. Oncology and Health Care Policy SECTION E: PREVENTION AND EARLY DETECTION
• 21. Discovery and Characterization of Cancer Genetic Susceptibility Alleles
• 22. Lifestyle and Cancer Prevention
• 23. Cancer Screening and Early Detection
• 24. Nicotine Dependence: Current Treatments and Future Directions SECTION F: TREATMENT
• 25. Cancer Pharmacology
• 26. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents
• 27. Basics of Radiation Therapy
• 28. Hematopoietic Stem Cell Transplantation
• 29. Gene Therapy in Oncology
• 30. Therapeutic Antibodies and Immunologic Conjugates
• 31. Complementary and Alternative Medicine PART II: PROBLEMS COMMON TO CANCER AND THERAPY SECTION A: HEMATOLOGIC PROBLEMS AND INFACTIONS
• 32. Disorders of Blood Cell Production in Clinical Oncology
• 33. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis
• 34. Infection in the Patient with Cancer SECTION B: SYMPTOM MANAGEMENT
• 35. Hypercalcemia
• 36. Tumor Lysis Syndrome
• 37. Cancer-Related Pain
• 38. Cancer Cachexia
• 39. Nausea and Vomiting SECTION C: TREATMENT COMPLICATIONS
• 40. Oral Complications
• 41. Dermatologic Toxicities of Anticancer Therapy
• 42. Cardiovascular Effects of Cancer Therapy
• 43. Reproductive Complications
• 44. Paraneoplastic Neurologic Syndromes
• 45. Neurologic complications
• 46. Endocrine Complications
• 47. Pulmonary Complications of Anticancer Treatment SECTION D: POST TREATMENT CONSIDERATIONS
• 48. Rehabilitation of Individuals with Cancer
• 49. Survivorship
• 50. Second Malignant Neoplasms
• 51. Caring for Patients at the End of Life SECTION E: LOCAL EFFECTS OF CANCER AND ITS METASTASIS
• 52. Acute Abdomen, Bowel Obstruction, and Fistula
• 53. Superior Vena Cava Syndrome
• 54. Spinal Cord Compression
• 55. Brain Metastases and Neoplastic Meningitis
• 56. Bone Metastases
• 57. Lung Metastases
• 58. Liver Metastases
• 59. Malignancy-Related Effusions SECTION F: SPECIAL POPULATIONS
• 60. Cancer in the Elderly: Biology, Prevention, and Treatment
• 61. Special Issues in Pregnancy
• 62. Human Immunodeficiency Virus (HIV) Infection and Cancer PART III: SPECIFIC MALIGNANCIES SECTION A
• 63. Cancer of the Central Nervous System SECTION B
• 64. Ocular Tumors
• 65. Cancer of the Head and Neck SECTION C: SKIN
• 66. Melanoma
• 67. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas SECTION D: ENDOCRINE
• 68. Cancer of the Endocrine System SECTION E: THORACIC
• 69. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer
• 70. Diseases of the Pleura and Mediastinum
• 71. Cancer of the Esophagus and Gastroesophageal Junction SECTION F: GASTROINTESTINAL
• 72. Cancer of the Stomach and Gastroesophageal Junction
• 73. Cancer of the Small Bowel
• 74. Colon Cancer
• 75. Cancer of the Rectum
• 76. Cancer of the Anal Canal
• 77. Liver and Bile Duct Cancer
• 78. Carcinoma of the Pancreas SECTION G: GENITOURINARY
• 79. Cancer of the Kidney
• 80. Carcinoma of the Bladder
• 81. Prostate Cancer
• 82. Cancer of the Penis
• 83. Testicular Cancer SECTION H: GYNECOLOGICAL
• 84. Cancers of the Cervix, Vulva, and Vagina
• 85. Cancer of the Endometrium
• 86. Ovaries and Fallopian Tubes
• 87. Gestational Trophoblastic Disease
• 88. Cancer of the Breast
• SECTION I: SARCOMAS
• 89. Sarcomas of Bone
• 90. Sarcomas of Soft Tissue SECTION J
• 91. Carcinoma of Unknown Primary SECTION K: PEDIATRICS
• 92. Pediatric Solid Tumors
• 93. Childhood Leukemia
• 94. Childhood Lymphoma SECTION L: HEMATOLOGICAL
• 95. Acute Leukemias in Adults
• 96. Myelodysplastic Syndromes
• 97. Myeloproliferative Disorders
• 98. Chronic Myeloid Leukemia
• 99. Chronic Lymphoid Leukemias
• 100. Hairy Cell Leukemia
• 101. Multiple Myeloma and Related Disorders
• 102. Hodgkin's Lymphoma
• 103. Non-Hodgkin Lymphoma
• 104. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma
• 105. Adult T-Cell Leukemia-Lymphoma.
• (source: Nielsen Book Data)

Easily accessible and clinically focused, Abeloff's Clinical Oncology, 6th Edition, covers recent advances in our understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression, new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading cancer experts, it offers clear, practical coverage of everything from basic science to multidisciplinary collaboration on diagnosis, staging, treatment and follow up. Includes new chapters on Cancer Metabolism and Clinical Trial Designs in Oncology and a standalone chapter on lifestyles and cancer prevention. Features extensive updates including the latest clinical practice guidelines, decision-making algorithms, and clinical trial implications, as well as new content on precision medicine, genetics, and PET/CT imaging. Includes revised diagnostic and treatment protocols for medical management, surgical considerations, and radiation oncology therapies, stressing a multispecialty, integrated approach to care. Helps you find information quickly with updated indexing related to management recommendations, focused fact summaries, updated key points at the beginning of each chapter ideal for quick reference and board review, and algorithms for patient evaluation, diagnosis, and treatment options. Offers more patient care coverage in disease chapters, plus new information on cancer as a chronic illness and cancer survivorship. Discusses today's key topics such as immuno-oncology, functional imaging, precision medicine, the application of genetics in pathologic diagnosis and sub-categorization of tumors as well as the association of chronic infectious diseases such as HIV and cancer. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
(source: Nielsen Book Data)